Investments
205Portfolio Exits
38Funds
8Latest Yonghua Capital News
Jun 3, 2022
NuProbe Global , a Houston, TX- and Shanghai, China-based genomics and molecular diagnostics company, raised $50M in funding. The round was co-led by AstraZeneca-CICC Fund, CR-CP Life Science Fund, and Panlin Capital. Existing investors Sequoia Capital China, Biotrack Capital, and Yonghua Capital and new investors Pappas Capital, Haoreng Capital, and Deguan Capital also participated in the round. The funds will be used to expand commercial operations, accelerate IVD product clinical studies and regulatory submissions, and develop new genomics and molecular diagnostics technologies. Led by Yingshuang Chai, CEO, and David Zhang, Co-Founder of NuProbe Global and CEO of NuProbe USA, NuProbe Global is a genomics and molecular diagnostics company with molecular diagnostic technologies to improve the sensitivity of sequencing mutations and copy number variations by over 10-fold. The company has sites in Houston, USA, Shanghai, China, and Suzhou, China. Since last round of fundraising in 2021, the company has engaged in research collaborations with several multinational companies, as well as clinical collaborations with over 400 hospitals. FinSMEs 03/06/2022
Yonghua Capital Investments
205 Investments
Yonghua Capital has made 205 investments. Their latest investment was in Elitesland as part of their Series A on June 6, 2022.
Yonghua Capital Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
6/15/2022 | Series A | Elitesland | $14.89M | Yes | ||
6/10/2022 | Series A | Gongdadi | No | 2 | ||
6/10/2022 | Series A | HJ Electronic | Yes | 1 | ||
6/2/2022 | Series B | |||||
5/5/2022 | Series A |
Date | 6/15/2022 | 6/10/2022 | 6/10/2022 | 6/2/2022 | 5/5/2022 |
|---|---|---|---|---|---|
Round | Series A | Series A | Series A | Series B | Series A |
Company | Elitesland | Gongdadi | HJ Electronic | ||
Amount | $14.89M | ||||
New? | Yes | No | Yes | ||
Co-Investors | |||||
Sources | 2 | 1 |
Yonghua Capital Portfolio Exits
38 Portfolio Exits
Yonghua Capital has 38 portfolio exits. Their latest portfolio exit was Asia Aroma on June 22, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
6/22/2022 | IPO | Public | 2 | ||
4/15/2022 | IPO | Public | 1 | ||
12/27/2021 | IPO | Public | 2 | ||
Date | 6/22/2022 | 4/15/2022 | 12/27/2021 | ||
|---|---|---|---|---|---|
Exit | IPO | IPO | IPO | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | Public | Public | ||
Sources | 2 | 1 | 2 |
Yonghua Capital Fund History
8 Fund Histories
Yonghua Capital has 8 funds, including Shanghai Xianghe Yong'an Equity Investment LP.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
9/28/2014 | Shanghai Xianghe Yong'an Equity Investment LP | Expansions & Growth | Closed | $48.49M | 1 |
12/29/2010 | Shanghai Xianghe Hongan Equity Investment Partnership LLP | ||||
10/31/2009 | Shanghai Xianghe Equity Investment LP | ||||
11/18/1999 | Beijing Zhijin Technology Investment Co. Ltd. | ||||
Shanghai Yongyu Equity Investment LP |
Closing Date | 9/28/2014 | 12/29/2010 | 10/31/2009 | 11/18/1999 | |
|---|---|---|---|---|---|
Fund | Shanghai Xianghe Yong'an Equity Investment LP | Shanghai Xianghe Hongan Equity Investment Partnership LLP | Shanghai Xianghe Equity Investment LP | Beijing Zhijin Technology Investment Co. Ltd. | Shanghai Yongyu Equity Investment LP |
Fund Type | Expansions & Growth | ||||
Status | Closed | ||||
Amount | $48.49M | ||||
Sources | 1 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.